Skip to main content
Smart Investors Daily
MD

NASDAQ · MDAI

Spectral AI, Inc.

Healthcare · Medical - Devices

$1.56

Up+$0.04 (+2.56%)

Updated Sep 11, 2026, 9:02 PM

SID Score

4.7/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
52.94M
P/E ratio
-3.06
Dividend yield
0.00%
52-week range
$1.18 – $2.97
Volume
138.58K
Avg. volume
592.78K

Price performance

MDAI price history

1M range · 20 trading sessions · Daily adjusted prices

MDAI closed at $1.56 after 20 trading sessions, down 9.83% for the selected period.

Last close
$1.56
Period change
-9.83%
Period low
$1.55
Period high
$1.73
Daily close
View OHLC price history
MDAI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 10, 2026$1.57$1.60$1.54$1.56138.58K
Sep 9, 2026$1.61$1.63$1.57$1.5882.5K
Sep 8, 2026$1.61$1.67$1.5807$1.61193.44K
Sep 4, 2026$1.56$1.59$1.56$1.5782.41K
Sep 3, 2026$1.58$1.59$1.55$1.5644.84K
Sep 2, 2026$1.57$1.60$1.55$1.56571.74K
Sep 1, 2026$1.58$1.59$1.545$1.5580.05K
Aug 31, 2026$1.57$1.59$1.5449$1.5784.88K
Aug 28, 2026$1.62$1.64$1.57$1.57100.15K
Aug 27, 2026$1.60$1.66$1.60$1.63116.67K
Aug 26, 2026$1.63$1.66$1.595$1.6197.78K
Aug 25, 2026$1.60$1.67$1.60$1.63157.08K
Aug 24, 2026$1.60$1.63$1.58$1.60108.34K
Aug 21, 2026$1.57$1.61$1.57$1.60138.61K
Aug 20, 2026$1.61$1.61$1.56$1.57174.44K
Aug 19, 2026$1.62$1.6391$1.57$1.62137.82K
Aug 18, 2026$1.63$1.668$1.61$1.61147.91K
Aug 17, 2026$1.67$1.72$1.62$1.64238.62K
Aug 14, 2026$1.74$1.76$1.67$1.68210.84K
Aug 13, 2026$1.59$1.73$1.59$1.73230.32K

Latest MDAI news

The latest Smart Investors Daily articles mentioning MDAI.

MDAI research

Overview

Company profile and research snapshot.

Company profile

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$3.50
Implied upside
Analysts
MDAI recent ratings
DateFirmRatingTarget
May 27, 2026BTIGBuy
May 26, 2026BTIGBuy
Mar 25, 2026BTIGBuy
Feb 10, 2026BTIGBuy
Nov 12, 2025BTIGBuy
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 1, 2026

Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference

Company to Highlight Growth Strategy and Readiness for 2026 Commercial Launch of FDA-Cleared DeepView® System for Burn IndicationDALLAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Vincent Capone, Chief Executive Officer, and David McGuire, Chief Financial Officer, are scheduled to present

Yahoo · Aug 13, 2026

MDAI: The Lull Between Approval and First Sale

By John Vandermosten, CFA NASDAQ: MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ: MDAI) reported second quarter 2026 results on August 11 th after the market close. Since the previous financial update in May, the company has received De Novo marketing authorization for the DeepView system in the burn indication and has accelerated its pre-commercialization efforts. It further

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.